These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16768544)

  • 1. Modeling of the temporal patterns of fluoxetine prescriptions and suicide rates in the United States.
    Milane MS; Suchard MA; Wong ML; Licinio J
    PLoS Med; 2006 Jun; 3(6):e190. PubMed ID: 16768544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents.
    Gibbons RD; Brown CH; Hur K; Marcus SM; Bhaumik DK; Erkens JA; Herings RM; Mann JJ
    Am J Psychiatry; 2007 Sep; 164(9):1356-63. PubMed ID: 17728420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is it just a marker for increased care?
    Hockey R
    PLoS Med; 2006 Sep; 3(9):e406; author reply e407. PubMed ID: 17002507
    [No Abstract]   [Full Text] [Related]  

  • 4. Antidepressant drug use: differences between psychiatrists and general practitioners. Results from a drug utilization observation study with fluoxetine.
    Dittmann RW; Linden M; Osterheider M; Schaaf B; Ohnmacht U; Weber HJ
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):28-34. PubMed ID: 9035225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between antidepressant medication treatment and suicide in adolescents.
    Olfson M; Shaffer D; Marcus SC; Greenberg T
    Arch Gen Psychiatry; 2003 Oct; 60(10):978-82. PubMed ID: 14557142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
    Nemeroff CB; Kalali A; Keller MB; Charney DS; Lenderts SE; Cascade EF; Stephenson H; Schatzberg AF
    Arch Gen Psychiatry; 2007 Apr; 64(4):466-72. PubMed ID: 17404123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline.
    Joyce PR; Mulder RT; Luty SE; Sullivan PF; McKenzie JM; Abbott RM; Stevens IF
    Aust N Z J Psychiatry; 2002 Jun; 36(3):384-91. PubMed ID: 12060188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prozac children.
    Hampshire M
    Nurs Times; 1998 Jan 21-27; 94(3):12-3. PubMed ID: 9510753
    [No Abstract]   [Full Text] [Related]  

  • 9. A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database.
    Murray ML; de Vries CS; Wong IC
    Arch Dis Child; 2004 Dec; 89(12):1098-102. PubMed ID: 15557040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine and suicide rates: suicide and the economy.
    Camargo CA; Bloch DA
    PLoS Med; 2006 Nov; 3(11):e501; author reply e504. PubMed ID: 17132055
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased use of antidepressants and decreasing suicide rates: a population-based study using Danish register data.
    Erlangsen A; Canudas-Romo V; Conwell Y
    J Epidemiol Community Health; 2008 May; 62(5):448-54. PubMed ID: 18413459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant dispensing trends in New Zealand between 2004 and 2007.
    Exeter D; Robinson E; Wheeler A
    Aust N Z J Psychiatry; 2009 Dec; 43(12):1131-40. PubMed ID: 20001412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant use and method of suicide in the United States: variation by age and sex, 1998-2007.
    Phillips JA; Nugent CN
    Arch Suicide Res; 2013; 17(4):360-72. PubMed ID: 24224670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety findings from naturalistic fluoxetine drug treatment in adolescent and young adult patients.
    Dittmann RW; Czekalla J; Hundemer HP; Linden M
    J Child Adolesc Psychopharmacol; 2000; 10(2):91-102. PubMed ID: 10933119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study of serotonin 1B receptor (A-161T) genetic polymorphism and suicidal behaviors and response to fluoxetine in major depressive disorder.
    Tsai SJ; Hong CJ; Yu YW; Chen TJ; Wang YC; Lin WK
    Neuropsychobiology; 2004; 50(3):235-8. PubMed ID: 15365222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation of the representativity of neuropsychiatrists and their patients in a drug utilization observation study on fluoxetine.
    Schaaf B; Linden M; Weber HJ
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):44-51. PubMed ID: 9035227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind fluoxetine in depressed alcoholic smokers.
    Cornelius JR; Salloum IM; Ehler JG; Jarrett PJ; Cornelius MD; Black A; Perel JM; Thase ME
    Psychopharmacol Bull; 1997; 33(1):165-70. PubMed ID: 9133770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A suicide prevention program in a region with a very high suicide rate.
    Szanto K; Kalmar S; Hendin H; Rihmer Z; Mann JJ
    Arch Gen Psychiatry; 2007 Aug; 64(8):914-20. PubMed ID: 17679636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the Saskatchewan health drug database for antidepressant use: the case of fluoxetine.
    Joffe RT; Iskedjian M; Einarson TR; O'Brien BJ; Stang MR
    Can J Clin Pharmacol; 2001; 8(3):146-52. PubMed ID: 11574897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of efficacy of l-5-hydroxytryptophan and fluoxetine in patients presenting with first depressive episode.
    Jangid P; Malik P; Singh P; Sharma M; Gulia AK
    Asian J Psychiatr; 2013 Feb; 6(1):29-34. PubMed ID: 23380314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.